|
Empiric piperacillin-tazobactam versus carbapenem in febrile neutropenia : increased incidence of invasive pulmonary aspergillosis (click for details) |
|
|
|
VITEK (R) MS in clinical and environmental Aspergillus spp. identification (click for details) |
|
|
|
Clinical outcomes in patients with chronic pulmonary aspergillosis following discontinuation of therapy (click for details) |
|
|
|
Invasive aspergillosis in renal transplant patients : a case control study (click for details) |
|
|
|
Modifications of triazole therapy and clinical outcomes in chronic pulmonary aspergillosis (click for details) |
|
|
|
Monitoring of invasive aspergillos is antifungal therapy by quantitative reverse transcriptase real-time polymerase chain reaction (qRT- PCR) (click for details) |
|
|
|
Chronic pulmonary aspergillosis in cystic fibrosis patients (click for details) |
|
|
|
Azole-resistant Aspergillus fumigatus at a university hospital in Belgium: a laboratorybased surveillance (click for details) |
|
|
|
Analysis of an HIV-positive sub-population in a cohort of patients with invasive Aspergillosis: clinical aspects, use of galactomannan and EORTC criteria validity (click for details) |
|
|
|
Levels of IL-6, IL-8, IL-10 and IL-17A in serum and IL-8 in bronchoalveolar lavage fluid are elevated in haematological patients with invasive pulmonary aspergillosis (click for details) |
|
|
